MBIO
Income statement / Annual
Last year (2023), Mustang Bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Mustang Bio, Inc.'s net income was -$51.60 M.
See Mustang Bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$2.23 M |
$3.03 M |
$2.31 M |
$1.79 M |
$1.37 M |
$630,000.00 |
$2,000.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$2.23 M |
-$3.03 M |
-$2.31 M |
-$1.79 M |
-$1.37 M |
-$630,000.00 |
-$2,000.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$39.18 M
|
$63.95 M
|
$55.71 M
|
$47.30 M
|
$36.32 M
|
$24.46 M
|
$20.38 M
|
$8.55 M
|
$4.04 M
|
| General & Administrative
Expenses |
$9.69 M
|
$12.21 M
|
$11.02 M
|
$9.51 M
|
$9.57 M
|
$6.76 M
|
$11.41 M
|
$2.82 M
|
$0.00
|
| Selling & Marketing
Expenses |
-$365,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$9.32 M
|
$12.21 M
|
$11.02 M
|
$9.51 M
|
$9.57 M
|
$6.76 M
|
$11.41 M
|
$2.82 M
|
$254,000.00
|
| Other Expenses |
$0.00 |
-$1.30 M |
$5.84 M |
$10.06 M |
$6.27 M |
$3.36 M |
$12.43 M |
$6.08 M |
$0.00 |
| Operating Expenses |
$48.50 M |
$74.86 M |
$66.72 M |
$56.81 M |
$45.89 M |
$31.22 M |
$31.79 M |
$11.36 M |
$4.30 M |
| Cost And Expenses |
$50.73 M |
$74.86 M |
$66.72 M |
$56.81 M |
$45.89 M |
$31.22 M |
$31.79 M |
$11.36 M |
$4.30 M |
| Interest Income |
$850,000.00 |
$689,000.00 |
$368,000.00 |
$708,000.00 |
$1.26 M |
$569,000.00 |
$505,000.00 |
$16,000.00 |
$0.00 |
| Interest Expense |
$1.31 M |
$3.36 M |
$15,000.00 |
$3.92 M |
$1.77 M |
$8,000.00 |
$8,000.00 |
$1.15 M |
$168,000.00 |
| Depreciation &
Amortization |
$2.23 M
|
$3.03 M
|
$2.31 M
|
$1.79 M
|
$1.37 M
|
$630,000.00
|
$2,000.00
|
-$22.71 M
|
$0.00
|
| EBITDA |
-$48.06 M
|
-$71.14 M
|
-$64.05 M
|
-$54.31 M
|
-$43.25 M
|
-$30.02 M
|
-$31.28 M
|
-$11.35 M
|
-$4.30 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$876,000.00
|
-$1.37 M
|
$353,000.00
|
-$3.21 M
|
-$504,000.00
|
$561,000.00
|
$497,000.00
|
-$24.02 M
|
-$168,000.00
|
| Income Before Tax |
-$51.60 M |
-$77.53 M |
-$66.37 M |
-$60.02 M |
-$46.39 M |
-$30.66 M |
-$31.29 M |
-$12.65 M |
-$4.47 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$1.37 M |
-$2.29 M |
$2.13 M |
$1.77 M |
$569,000.00 |
$505,000.00 |
$23.86 M |
$0.00 |
| Net Income |
-$51.60 M |
-$78.89 M |
-$64.08 M |
-$62.15 M |
-$48.16 M |
-$30.66 M |
-$31.29 M |
-$12.65 M |
-$4.47 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-6 |
-11.44 |
-10.94 |
-17.73 |
-20.03 |
-17.07 |
-18.58 |
-7.24 |
-6.7 |
| EPS Diluted |
-6 |
-11.44 |
-10.94 |
-17.73 |
-20.03 |
-17.07 |
-18.58 |
-7.24 |
-6.7 |
| Weighted Average Shares
Out |
$8.60 M
|
$6.90 M
|
$5.86 M
|
$3.51 M
|
$2.40 M
|
$1.80 M
|
$1.68 M
|
$1.75 M
|
$666,213.00
|
| Weighted Average Shares
Out Diluted |
$8.60 M
|
$6.90 M
|
$5.86 M
|
$3.51 M
|
$2.40 M
|
$1.80 M
|
$1.68 M
|
$1.75 M
|
$666,213.00
|
| Link |
|
|
|
|
|
|
|
|
|
